3 reports of this reaction
3.4% of all AIR reports
#2 most reported adverse reaction
SINUS TACHYCARDIA is the #2 most commonly reported adverse reaction for AIR, manufactured by Strate Welding Supply Co., Inc.. There are 3 FDA adverse event reports linking AIR to SINUS TACHYCARDIA. This represents approximately 3.4% of all 87 adverse event reports for this drug.
Patients taking AIR who experience sinus tachycardia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SINUS TACHYCARDIA is moderately reported among AIR users, representing a notable but not dominant share of adverse events.
In addition to sinus tachycardia, the following adverse reactions have been reported for AIR:
The following drugs have also been linked to sinus tachycardia in FDA adverse event reports:
SINUS TACHYCARDIA has been reported as an adverse event in 3 FDA reports for AIR. This does not prove causation, but indicates an association observed in post-market surveillance data.
SINUS TACHYCARDIA accounts for approximately 3.4% of all adverse event reports for AIR, making it one of the most commonly reported side effect.
If you experience sinus tachycardia while taking AIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.